In short. What adding volume again can cost, and the options for a face that does not need anything added. Why treating less keeps more choices open.
Key points
- Over-treatment is harder to correct than under-treatment.
- Adding volume is straightforward; removing it depends on which substance class was used, and where no reversal agent applies there may be no comparable option.
- Treating less keeps more choices open, which is the practical form of the argument for restraint.
The default next step for a face that has been treated is usually another treatment. It is worth stating plainly what that costs, and what the alternatives are, because the choice is not between doing something and doing nothing. It is between several things, one of which is doing less, and only one of which is adding volume.
The risks do not diminish with repetition
Every injection carries the risk of vascular occlusion, which is material blocking a blood vessel. It is a time-critical emergency that can cause skin loss and, rarely, vision loss, and the outcome depends on how quickly it is recognised. Severe pain out of proportion to the injection, or skin turning white, grey, mottled or dusky, requires immediate assessment, and any change in vision requires emergency care. Firm lumps and nodules occur, and delayed inflammatory reactions appearing weeks to months after treatment occur as well. None of this becomes less likely because the area has been treated before.
Adding volume rarely fixes an over-filled appearance
This is the point most often lost. A face that reads as over-filled is carrying more volume than its structure supports, and the appearance is produced by that excess. Adding more does not correct it; it usually increases it, and it does so in a way that is harder to reverse than the original treatment, because the second addition is subject to the same limits on removal as the first. Where the appearance is produced by volume, the direction of travel is less, not more.
The asymmetry that decides most plans
Over-treatment is harder to correct than under-treatment. Adding volume is straightforward; removing it depends on which substance class was used, and where no reversal agent applies there may be no comparable option. Treating less keeps more choices open, which is the practical form of the argument for restraint.
The alternatives, in order of what they cost
Waiting is first: treatment that is no longer being added to changes slowly on its own, so six months of observation answers a question no examination can. Dissolving is second, where the substance allows it, with the limits set out elsewhere in this review. Skin-directed treatment is third, where texture or tone rather than volume is the dominant complaint. Surgical assessment is fourth, where the appearance is produced by tissue that has descended or skin that is lax.
What to do with this
Nothing here is a recommendation for or against treatment, and the decision belongs with a clinician who has examined the face. What the review can do is remove the assumption that more is the default next step. Where the finding is excess volume, the options run in the other direction, and where the finding is something else entirely, the treatment is for that instead.
Seek care if
- Severe pain out of proportion to an injection, or skin turning white, grey, mottled or dusky — a vascular emergency; seek care immediately.
- Any change in vision after a facial injection — emergency care immediately.
- Fever, spreading redness, warmth or discharge from an injection site, or a wound that is not healing.
Frequently asked questions
What is the risk of adding more filler to a treated face?
The risks are those of any injection, and they do not diminish with repetition: vascular occlusion, which is time-critical; firmness and nodules; delayed inflammatory reactions. There is also the specific risk that adding volume does not address the appearance, because a face that reads as over-filled rarely reads that way for want of more volume.
Is there an alternative that is not another treatment?
Waiting is a real option, and an informative one. Treatment that is no longer being added to changes slowly on its own, so a face observed over six months answers a question no examination can: how much of what is disliked is still changing. Photographs taken now and later make that comparison concrete.
When is an operation the honest answer?
Where the appearance is produced by tissue that has descended or skin that is lax, since neither is corrected by adding volume or by removing it. An operation addresses the tissue itself, it is a larger decision with a longer recovery, and it is the option a plan focused on injectables tends to leave out.
Risks & Limitations
- Every filler result is temporary, and maintenance treatment is usually part of a plan over years.
- Over-treatment is harder to correct than under-treatment, and removing volume depends on which substance class was used.
- Vascular occlusion is a time-critical emergency that can cause skin loss and, rarely, vision loss.
- Dissolving is a treatment with its own risks, not a reset: it acts on one substance class and cannot be confirmed to have removed everything.
When to Seek Care
- Severe pain out of proportion to an injection, or skin turning white, grey, mottled or dusky — a vascular emergency; seek care immediately.
- Any change in vision after a facial injection — seek emergency care immediately.
- A firm tender lump, or redness and swelling appearing weeks to months after treatment rather than settling.
- Skin breakdown, blistering or a wound at an injection site, or fever with spreading redness and warmth.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It is an evidence review rather than a booking page, and it does not steer anyone towards treatment. Discuss your own case with a qualified clinician; to ask a question about the content of this review, see Contact & Consultation.